Biohacking 2 MIN READ

Ultrahuman Raises $17.5 mn Series A

Over a billion people in the world suffer from metabolic health disorders. Many more have early symptoms / precursors of a metabolic disorder.

Written by Team Ultrahuman

Oct 14, 2022
Ultrahuman Raises SeriesA 1

Over a billion people in the world suffer from metabolic health disorders. Many more have early symptoms / precursors of a metabolic disorder.

Metabolic disorders have been linked to Type 2 diabetes and other major disorders like PCOS, fatty liver disease, high blood pressure, and many more. In fact, the relationship between elevated levels of blood glucose and Alzheimer’s is so strong that some people call it ‘diabetes of the brain’ or ‘Type 3 diabetes’.

Balanced nutrition and exercise seem like the most effective ways to prevent and reverse a metabolic disorder. Though, it is hard to assess if these are really working for you.

Traditional markers like body mass index, weight, and point-in-time blood tests only tell the partial story and don’t capture all aspects of your lifestyle that affect your health.

When we started Ultrahuman, we asked ourselves the question ‘How does one eat and workout based on the specifics of their own body and their own goals?’. Given there’s so much out there around ‘what’s an ideal diet’ or the ‘most effective exercise routine’ — to figure out how fitness protocols such as eating healthy and exercising lead to better health in a quantifiable way seemed like a big confusing black box.

We wanted to change that by giving people access to a radical new approach—An approach that utilizes biomarkers to tell you how your body reacts to a certain type of food, how to fuel efficiently for exercise, and how to eat for better sleep. Our mission is ‘to help people optimize their health by providing them access to deeply personalized insights and real-time nudges.’

Today, our commitment to solving the metabolic health problem is strengthened further.

We have raised $17.5 million in our Series A funding from Alpha Wave Incubation (AWI), which is backed by DisruptAD and managed by Falcon Edge, Steadview Capital, Nexus Venture Partners, Blume Ventures and, Utsav Somani’s iSeed fund along with marquee founders and angel investors like Tiger Global’s Scott Schleifer, Sandeep Singhal, Kunal Shah, Sujeet Kumar, Deepinder Goyal, Gunjan Patidar, Gaurav Munjal, Revant Bhate, Mohit Gupta, Vikram Dhingra and Roman Saini.

What this means for us:

This will give us the ability to launch new geographies, strengthen our teams and improve our life sciences research capabilities. 

In summary, there are two things we’re deeply committed to:

  1. Making Ultrahuman’s platform accessible to millions of people globally.
  2. Improving the quality of our real-time health scores via better quality / new biomarkers.

Helping millions get fit metabolically is a mighty goal. This problem cannot be solved by an individual or a single large company. It would take everyone — you, our partners, investors, and competitors to work together on this massive crisis to make a significant impact in reversing it. It’s time!

Subscribe to Metablog

Get the best, most science backed, and latest in metabolic health delivered to your inbox each week.

Thank you for subscribing!

Please check your email for confirmation message.

    You can unsubscribe at any time, no hard feelings. Privacy Policy

    Loading please wait...